tacrolimus

Tacrolimus is a lipid of Polyketides (PK) class. Tacrolimus is associated with abnormalities such as Renal glomerular disease. The involved functions are known as inhibitors, Fungicidal activity, Metabolic Inhibition, Excretory function and Dephosphorylation. Tacrolimus often locates in Hepatic, Mitochondrial matrix and Inner mitochondrial membrane. The associated genes with Tacrolimus are RHOA gene and BGN gene.

Cross Reference

Introduction

To understand associated biological information of tacrolimus, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with tacrolimus?

tacrolimus is suspected in Renal glomerular disease, Candidiasis, Mycoses, PARKINSON DISEASE, LATE-ONSET, Morphologically altered structure, Skin Diseases, Infectious and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with tacrolimus

MeSH term MeSH ID Detail
Myoclonic Cerebellar Dyssynergia D002527 1 associated lipids
Lichen Nitidus D017513 1 associated lipids
Lichenoid Eruptions D017512 1 associated lipids
Lymphocele D008210 1 associated lipids
Colitis, Collagenous D046729 1 associated lipids
Malacoplakia D008287 1 associated lipids
Hand Injuries D006230 1 associated lipids
Beckwith-Wiedemann Syndrome D001506 1 associated lipids
Eye Diseases, Hereditary D015785 1 associated lipids
Feline Infectious Peritonitis D016766 1 associated lipids
Meningitis, Cryptococcal D016919 1 associated lipids
Oculomotor Nerve Diseases D015840 1 associated lipids
Cutis Laxa D003483 1 associated lipids
Invasive Pulmonary Aspergillosis D055744 1 associated lipids
Intestinal Volvulus D045822 1 associated lipids
IgG Deficiency D017099 1 associated lipids
Deltaretrovirus Infections D006800 1 associated lipids
Hepatopulmonary Syndrome D020065 1 associated lipids
Herpes Labialis D006560 1 associated lipids
End Stage Liver Disease D058625 1 associated lipids
Nocturnal Myoclonus Syndrome D020189 1 associated lipids
Uveomeningoencephalitic Syndrome D014607 1 associated lipids
Myelitis D009187 1 associated lipids
Pseudohypoaldosteronism D011546 1 associated lipids
Dendritic Cell Sarcoma, Interdigitating D054739 1 associated lipids
Polymyositis D017285 1 associated lipids
Scorpion Stings D065008 1 associated lipids
Rotavirus Infections D012400 1 associated lipids
Netherton Syndrome D056770 1 associated lipids
Lymphocytic Choriomeningitis D008216 1 associated lipids
Erythroplasia D004919 1 associated lipids
Hepatic Veno-Occlusive Disease D006504 1 associated lipids
West Nile Fever D014901 1 associated lipids
Hypoalbuminemia D034141 1 associated lipids
Arm Injuries D001134 1 associated lipids
Intussusception D007443 1 associated lipids
Thrombotic Microangiopathies D057049 1 associated lipids
Autoimmune Diseases of the Nervous System D020274 1 associated lipids
Lupus Erythematosus, Discoid D008179 1 associated lipids
Feline Acquired Immunodeficiency Syndrome D016181 1 associated lipids
Budd-Chiari Syndrome D006502 1 associated lipids
AIDS-Associated Nephropathy D016263 1 associated lipids
Oral Ulcer D019226 1 associated lipids
Epidermolysis Bullosa Dystrophica D016108 1 associated lipids
Primary Graft Dysfunction D055031 1 associated lipids
Esophageal Perforation D004939 1 associated lipids
Epididymitis D004823 1 associated lipids
Pruritus Vulvae D011539 1 associated lipids
Central Serous Chorioretinopathy D056833 1 associated lipids
Migraine with Aura D020325 1 associated lipids
Porokeratosis D017499 1 associated lipids
Lentigo D007911 1 associated lipids
Mutism D009155 1 associated lipids
Amyloid Neuropathies D017772 1 associated lipids
Cervical Intraepithelial Neoplasia D018290 1 associated lipids
Flaviviridae Infections D018178 1 associated lipids
Idiopathic Interstitial Pneumonias D054988 1 associated lipids
Dysuria D053159 1 associated lipids
Denys-Drash Syndrome D030321 1 associated lipids
Akinetic Mutism D000405 1 associated lipids
Sleep Apnea, Central D020182 1 associated lipids
Orchitis D009920 1 associated lipids
Phyllodes Tumor D003557 1 associated lipids
Meningitis, Fungal D016921 1 associated lipids
Malocclusion, Angle Class II D008312 1 associated lipids
Vulvar Lichen Sclerosus D007724 1 associated lipids
Cardiomyopathy, Restrictive D002313 1 associated lipids
Paraparesis, Tropical Spastic D015493 1 associated lipids
Neurodermatitis D009450 1 associated lipids
Posterior Leukoencephalopathy Syndrome D054038 1 associated lipids
Ecthyma, Contagious D004474 1 associated lipids
Priapism D011317 1 associated lipids
Panniculitis, Lupus Erythematosus D015435 1 associated lipids
Retrognathia D063173 1 associated lipids
Mediastinal Diseases D008477 1 associated lipids
Hypophosphatemia D017674 1 associated lipids
Leukemia, Myeloid, Chronic-Phase D015466 1 associated lipids
Myelinolysis, Central Pontine D017590 1 associated lipids
Protoporphyria, Erythropoietic D046351 1 associated lipids
Smooth Muscle Tumor D018235 1 associated lipids
Coproporphyria, Hereditary D046349 1 associated lipids
Ichthyosiform Erythroderma, Congenital D016113 1 associated lipids
Kaposi Varicelliform Eruption D007617 1 associated lipids
Lacerations D022125 1 associated lipids
Megacolon, Toxic D008532 1 associated lipids
Tinea Capitis D014006 1 associated lipids
Digestive System Fistula D016154 1 associated lipids
Crigler-Najjar Syndrome D003414 1 associated lipids
Leukoplakia, Oral D007972 1 associated lipids
Peroneal Neuropathies D020427 1 associated lipids
Poxviridae Infections D011213 1 associated lipids
Lymphohistiocytosis, Hemophagocytic D051359 1 associated lipids
Rheumatoid Nodule D012218 1 associated lipids
Hernia, Ventral D006555 1 associated lipids
Hepatitis, Autoimmune D019693 1 associated lipids
Moyamoya Disease D009072 1 associated lipids
Polyomavirus Infections D027601 1 associated lipids
Echinostomiasis D004451 1 associated lipids
Multiple Endocrine Neoplasia Type 2a D018813 1 associated lipids
Apraxias D001072 1 associated lipids
Per page 10 20 50 100 | Total 613

PubChem Associated disorders and diseases

What pathways are associated with tacrolimus

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with tacrolimus?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with tacrolimus?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with tacrolimus?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with tacrolimus?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with tacrolimus?

There are no associated biomedical information in the current reference collection.

NCBI Entrez Crosslinks

All references with tacrolimus

Download all related citations
Per page 10 20 50 100 | Total 15051
Authors Title Published Journal PubMed Link
Gökceoğlu AU et al. Circulating endothelial cells in pediatric renal transplant recipients. 2013 Pediatr. Nephrol. pmid:24018796
Kim YJ et al. Impact of combined acute rejection on BK virus-associated nephropathy in kidney transplantation. 2013 J. Korean Med. Sci. pmid:24339698
Carcas-Sansuán AJ et al. Conversion from Prograf to Advagraf in adolescents with stable liver transplants: comparative pharmacokinetics and 1-year follow-up. 2013 Liver Transpl. pmid:23894093
Howell J et al. Cyclosporine and tacrolimus have inhibitory effects on toll-like receptor signaling after liver transplantation. 2013 Liver Transpl. pmid:23894100
Zhang CW et al. [Establishment of a real-time PCR assay for simultaneously detecting human BKV and CMV DNA and its application in renal transplantation recipients]. 2013 Bing Du Xue Bao pmid:23895006
Cardona M et al. [Association of everolimus with tacrolimus during the first year after heart transplantation: initial experience]. 2013 Med Clin (Barc) pmid:23384432
Gray FL et al. Predictive value of the Pediatric Ulcerative Colitis Activity Index in the surgical management of ulcerative colitis. 2013 J. Pediatr. Surg. pmid:23895969
Yildirim R et al. Treatment of pure red-cell aplasia with cyclosporine in a renal transplant patient. 2013 Exp Clin Transplant pmid:22891934
März AM et al. Large FK506-binding proteins shape the pharmacology of rapamycin. 2013 Mol. Cell. Biol. pmid:23358420
Foroncewicz B et al. A comparison between two tacrolimus-based immunosuppression regimens in renal transplant recipients: 7-year follow-up. 2013 Ann. Transplant. pmid:23896824
Danby SG and Cork MJ The effects of pimecrolimus on the innate immune response in atopic dermatitis. 2013 Br. J. Dermatol. pmid:23362967
Yoon SH et al. CYP3A and ABCB1 genetic polymorphisms on the pharmacokinetics and pharmacodynamics of tacrolimus and its metabolites (M-I and M-III). 2013 Transplantation pmid:23364483
Yu JJ et al. Inhibition of calcineurin in the prefrontal cortex induced depressive-like behavior through mTOR signaling pathway. 2013 Psychopharmacology (Berl.) pmid:22875481
Rosado-Rubio C et al. Delayed introduction of tacrolimus in sub-optimal kidneys. A short-term follow-up study in the University Hospital of Salamanca. 2013 Nefrologia pmid:23364645
Spriet I et al. Switching from intravenous to oral tacrolimus and voriconazole leads to a more pronounced drug-drug interaction. 2013 Eur. J. Clin. Pharmacol. pmid:22878691
Nakase H [Tacrolimus therapy for patients with ulcerative colitis]. 2013 Nihon Shokakibyo Gakkai Zasshi pmid:24189819
Abei M et al. [Nonspecific reacting materials that interferes tacrolimus assay by ACMIA]. 2013 Rinsho Byori pmid:24450102
Yuda S et al. [Sodium-losing nephropathy caused by tacrolimus after allogeneic hematopoietic stem cell transplantation]. 2013 Rinsho Ketsueki pmid:24452151
Nakane S [Calcineurin inhibitors and IVIg in the treatment of myasthenia gravis]. 2013 Rinsho Shinkeigaku pmid:24291970
Nobuoka Y et al. Immune response following liver transplantation compared to kidney transplantation: usefulness of monitoring peripheral blood CD4+ adenosine triphosphate activity and cytochrome P450 3A5 genotype assay. 2013 Clin. Dev. Immunol. pmid:24454479
Nanaeva BA and Vardanian AV [Tacrolimus in perianal manifestations of Crohn's disease]. 2013 Eksp Klin Gastroenterol pmid:24294772
Kovacs D et al. Follow up of lung transplant recipients using an electronic nose. 2013 J Breath Res pmid:23445553
Gijsen VM et al. Prevalence of renal dysfunction in tacrolimus-treated pediatric transplant recipients: a systematic review. 2013 Pediatr Transplant pmid:23448292
Okamoto M et al. Successful treatment with tacrolimus in a case of lung-dominant connective tissue disease. 2013 Intern. Med. pmid:23448773
Muili KA et al. Bile acids induce pancreatic acinar cell injury and pancreatitis by activating calcineurin. 2013 J. Biol. Chem. pmid:23148215
Brzezińska B et al. Factors associated with glucose metabolism disorders after kidney transplantation. 2013 Endokrynol Pol pmid:23450443
Akelma AZ et al. A diagnostic dilemma: inflammatory linear verrucous epidermal nevus versus linear psoriasis. 2013 J. Pediatr. pmid:23149170
Lemaitre F et al. Monitoring of tacrolimus concentrations in peripheral blood mononuclear cells: application to cardiac transplant recipients. 2013 Clin. Biochem. pmid:23454394
Trunečka P [Immunosuppression after liver transplant, now and in future]. 2013 Vnitr Lek pmid:24007221
Telkes G et al. Kidney transplantation in hereditary coproporphyria using tacrolimus and mycophenolate mofetil: a case report. 2013 Transplant. Proc. pmid:24315002
Azzi JR et al. Calcineurin inhibitors: 40 years later, can't live without ... 2013 J. Immunol. pmid:24319282
Praehauser C et al. Risk factors and outcome of expanded-criteria donor kidney transplants in patients with low immunological risk. 2013 Swiss Med Wkly pmid:24222631
Matsuoka K and Hibi T Treatment guidelines in inflammatory bowel disease: the Japanese perspectives. 2013 Dig Dis pmid:24246989
Kim CR and Lee DY Combination of narrow-band ultraviolet B and topical tacrolimus is effective for segmental vitiligo. 2013 Int. J. Dermatol. pmid:24073911
Ali FR and Lyon CC Tacrolimus toxicity following topical treatment of perianal Crohn's disease: an admonitory anecdote. 2013 J Crohns Colitis pmid:24076430
Palacín M et al. FK506 affects mitochondrial protein synthesis and oxygen consumption in human cells. 2013 Cell Biol. Toxicol. pmid:24077807
Tsuchiya T et al. Comparison of pharmacokinetics and pathology for low-dose tacrolimus once-daily and twice-daily in living kidney transplantation: prospective trial in once-daily versus twice-daily tacrolimus. 2013 Transplantation pmid:23792649
Hu AB et al. Safety and efficacy of four steroid-minimization protocols in liver transplant recipients: 3-year follow-up in a single center. 2013 J Dig Dis pmid:23134408
Kosugi K et al. A longitudinal study of the effect of experimental osteoporosis on bone trabecular structure in the rat mandibular condyle. 2013 Cranio pmid:23795404
Issa N et al. Calcineurin inhibitor nephrotoxicity: a review and perspective of the evidence. 2013 Am. J. Nephrol. pmid:23796509
Durand P et al. Tacrolimus dose requirement in pediatric liver transplantation: influence of CYP3A5 gene polymorphism. 2013 Pharmacogenomics pmid:23837476
Gijsen VM et al. CYP3A4*22 and CYP3A combined genotypes both correlate with tacrolimus disposition in pediatric heart transplant recipients. 2013 Pharmacogenomics pmid:23837477
Honda A et al. Omission of day-11 MTX, in combination with tacrolimus, is not associated with increased risk of acute graft-versus-host disease after allo-BMT. 2013 Bone Marrow Transplant. pmid:22751000
Pitarch G and Giner F Periorbital necrobiosis lipoidica. 2013 Actas Dermosifiliogr pmid:23871211
Piram M et al. Short- and long-term outcome of linear morphoea in children. 2013 Br. J. Dermatol. pmid:24032480
Mouzaki M et al. Basiliximab with delayed introduction of calcineurin inhibitors as a renal-sparing protocol following liver transplantation in children with renal impairment. 2013 Pediatr Transplant pmid:24118898
Vannaprasaht S et al. Personalized tacrolimus doses determined by CYP3A5 genotype for induction and maintenance phases of kidney transplantation. 2013 Clin Ther pmid:24120259
Hilbrands R et al. Predictive factors of allosensitization after immunosuppressant withdrawal in recipients of long-term cultured islet cell grafts. 2013 Transplantation pmid:23857001
Zlotkowski K et al. Small-molecule mechanism of action studies in Caenorhabditis elegans. 2013 Chembiochem pmid:24123757
Wang SE et al. Hepatic veno-occlusive disease related to tacrolimus after pancreas transplantation. 2013 J Chin Med Assoc pmid:23602212
Sapoznikov D et al. Heart rate response to blood pressure variations: sympathetic activation versus baroreflex response in patients with end-stage renal disease. 2013 PLoS ONE pmid:24124623
Fujii H et al. Nonlinear decoding and asymmetric representation of neuronal input information by CaMKIIα and calcineurin. 2013 Cell Rep pmid:23602566
Hodge G et al. Up-regulation of alternate co-stimulatory molecules on proinflammatory CD28null T cells in bronchiolitis obliterans syndrome. 2013 Clin. Exp. Immunol. pmid:23607447
Rodríguez-Perálvarez M et al. Early tacrolimus exposure after liver transplantation: relationship with moderate/severe acute rejection and long-term outcome. 2013 J. Hepatol. pmid:23023010
Ben Fredj N et al. Tacrolimus therapeutic drug monitoring in Tunisian renal transplant recipients: effect of post-transplantation period. 2013 Transpl. Immunol. pmid:23608723
Yin ZQ et al. Effects of topical tacrolimus 0.03% on long-term suberythemal ultraviolet B-irradiated epidermal Langerhans cells in mice. 2013 J Eur Acad Dermatol Venereol pmid:22471949
De Bruyne R et al. Post-transplant food allergy in children is associated with liver and not with renal transplantation: a monocentric comparative study. 2013 Eur. J. Pediatr. pmid:23609525
Ciftci HS et al. Effect of MDR1 polymorphisms on the blood concentrations of tacrolimus in Turkish renal transplant patients. 2013 Transplant. Proc. pmid:23622581
Hammerstrom AE et al. Tacrolimus-associated posterior reversible encephalopathy syndrome in hematopoietic allogeneic stem cell transplantation. 2013 Am. J. Hematol. pmid:23460378
Briem-Richter A et al. Peripheral blood biomarkers for the characterization of alloimmune reactivity after pediatric liver transplantation. 2013 Pediatr Transplant pmid:24164827
Sheu JJ et al. Innate immune response after acute myocardial infarction and pharmacomodulatory action of tacrolimus in reducing infarct size and preserving myocardial integrity. 2013 J. Biomed. Sci. pmid:24165293
McDiarmid SV Adolescence: challenges and responses. 2013 Liver Transpl. pmid:24166838
Jensen JM et al. Effects of pimecrolimus compared with triamcinolone acetonide cream on skin barrier structure in atopic dermatitis: a randomized, double-blind, right-left arm trial. 2013 Acta Derm. Venereol. pmid:23571785
Gorgan M et al. Pulmonary hemorrhage with capillaritis secondary to mycophenolate mofetil in a heart-transplant patient. 2013 Arch. Pathol. Lab. Med. pmid:24168511
Vafadari R et al. Tacrolimus inhibits NF-κB activation in peripheral human T cells. 2013 PLoS ONE pmid:23573283
Elens L et al. Single-nucleotide polymorphisms in P450 oxidoreductase and peroxisome proliferator-activated receptor-α are associated with the development of new-onset diabetes after transplantation in kidney transplant recipients treated with tacrolimus. 2013 Pharmacogenet. Genomics pmid:24113216
Dai Y et al. Liposomes containing bile salts as novel ocular delivery systems for tacrolimus (FK506): in vitro characterization and improved corneal permeation. 2013 Int J Nanomedicine pmid:23690687
Sinha R and Marks SD Tacrolimus toxicity secondary to diarrhoea in nephrotic syndrome. 2013 Acta Paediatr. pmid:23573873
Takada Y et al. Randomized, multicenter trial comparing tacrolimus plus mycophenolate mofetil to tacrolimus plus steroids in hepatitis C virus-positive recipients of living donor liver transplantation. 2013 Liver Transpl. pmid:23696054
Hung TC et al. Investigation of SSEA-4 binding protein in breast cancer cells. 2013 J. Am. Chem. Soc. pmid:23574147
Keating GM and Lyseng-Williamson KA Everolimus: a guide to its use in liver transplantation. 2013 BioDrugs pmid:23696253
Trotter JF et al. Early use of renal-sparing agents in liver transplantation: a closer look. 2013 Liver Transpl. pmid:23696464
Zheng S et al. Tacrolimus placental transfer at delivery and neonatal exposure through breast milk. 2013 Br J Clin Pharmacol pmid:23528073
Ishii T et al. Treatment of cerebral ischemia-reperfusion injury with PEGylated liposomes encapsulating FK506. 2013 FASEB J. pmid:23241312
Nwaba A et al. Tacrolimus-induced thrombotic microangiopathy in orthotopic liver transplant patients: case series of four patients. 2013 Intern Med J pmid:23441660
Hofmann M et al. Validation of Dermaphot(®) for the assessment of steroid-induced skin atrophy. 2013 Arch. Dermatol. Res. pmid:23242470
Koop DR et al. Analysis of tacrolimus and creatinine from a single dried blood spot using liquid chromatography tandem mass spectrometry. 2013 J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. pmid:23548676
Lewis RE et al. Tacrolimus enhances the potency of posaconazole against Rhizopus oryzae in vitro and in an experimental model of mucormycosis. 2013 J. Infect. Dis. pmid:23242544
Vafadari R et al. Genetic polymorphisms in ABCB1 influence the pharmacodynamics of tacrolimus. 2013 Ther Drug Monit pmid:23743668
Pople PV and Singh KK Development and evaluation of colloidal modified nanolipid carrier: application to topical delivery of tacrolimus, Part II--in vivo assessment, drug targeting, efficacy, and safety in treatment for atopic dermatitis. 2013 Eur J Pharm Biopharm pmid:23246619
Sevc J et al. Effective long-term immunosuppression in rats by subcutaneously implanted sustained-release tacrolimus pellet: effect on spinally grafted human neural precursor survival. 2013 Exp. Neurol. pmid:23748136
Nakagawa Y et al. Induction of rapid apoptosis for class I MHC molecule-restricted CD8(+) HIV-1 gp160-specific murine activated CTLs by free antigenic peptide in vivo. 2013 Int. Immunol. pmid:22945875
Pinelli NR et al. Coadministration of liraglutide with tacrolimus in kidney transplant recipients: a case series. 2013 Diabetes Care pmid:24065848
Ramser EM et al. Amyloid-β oligomers induce tau-independent disruption of BDNF axonal transport via calcineurin activation in cultured hippocampal neurons. 2013 Mol. Biol. Cell pmid:23783030
Niioka T et al. Pharmaceutical and genetic determinants for interindividual differences of tacrolimus bioavailability in renal transplant recipients. 2013 Eur. J. Clin. Pharmacol. pmid:23733010
Tanaka Y et al. Prevention of joint destruction by tacrolimus in patients with early rheumatoid arthritis: a post hoc analysis of a double-blind, randomized, placebo-controlled study. 2013 Mod Rheumatol pmid:23271170
Murase S Signal transducer and activator of transcription 3 (STAT3) degradation by proteasome controls a developmental switch in neurotrophin dependence. 2013 J. Biol. Chem. pmid:23733189
Min SI et al. Conversion of twice-daily tacrolimus to once-daily tacrolimus formulation in stable pediatric kidney transplant recipients: pharmacokinetics and efficacy. 2013 Am. J. Transplant. pmid:23734831
Valdivieso N et al. Tacrolimus dose individualization in "de novo" patients after 10 years of experience in liver transplantation: pharmacokinetic considerations and patient pathophysiology. 2013 Int J Clin Pharmacol Ther pmid:23735178
Egli A et al. Comparison of the effect of standard and novel immunosuppressive drugs on CMV-specific T-cell cytokine profiling. 2013 Transplantation pmid:23274966
Hebert MF et al. Interpreting tacrolimus concentrations during pregnancy and postpartum. 2013 Transplantation pmid:23274970
Quigley MA et al. Development of a reliable model of total abdominal wall transplantation. 2013 Plast. Reconstr. Surg. pmid:24076687
Sha T et al. Establishment and validation of a new semi-chronic dextran sulfate sodium-induced model of colitis in mice. 2013 Int. Immunopharmacol. pmid:23142502
Bramham K et al. Breastfeeding and tacrolimus: serial monitoring in breast-fed and bottle-fed infants. 2013 Clin J Am Soc Nephrol pmid:23349333
Khaled SK et al. A phase II study of sirolimus, tacrolimus and rabbit anti-thymocyte globulin as GVHD prophylaxis after unrelated-donor PBSC transplant. 2013 Bone Marrow Transplant. pmid:23000644
Mei Y et al. Stabilization of the skeletal muscle ryanodine receptor ion channel-FKBP12 complex by the 1,4-benzothiazepine derivative S107. 2013 PLoS ONE pmid:23349825
Martínez-Castro M et al. Taxonomy and chemically semi-defined media for the analysis of the tacrolimus producer 'Streptomyces tsukubaensis'. 2013 Appl. Microbiol. Biotechnol. pmid:22990582
Gladstone DE et al. Partially mismatched transplantation and human leukocyte antigen donor-specific antibodies. 2013 Biol. Blood Marrow Transplant. pmid:23353119
Sharma P and Barman P Everolimus for liver transplant recipients: is it ready for prime time? 2013 Gastroenterology pmid:23260492
Nara M et al. Effect of itraconazole on the concentrations of tacrolimus and cyclosporine in the blood of patients receiving allogeneic hematopoietic stem cell transplants. 2013 Eur. J. Clin. Pharmacol. pmid:23354810